MX2015013993A - Procedimientos y series para su uso en los mismos. - Google Patents
Procedimientos y series para su uso en los mismos.Info
- Publication number
- MX2015013993A MX2015013993A MX2015013993A MX2015013993A MX2015013993A MX 2015013993 A MX2015013993 A MX 2015013993A MX 2015013993 A MX2015013993 A MX 2015013993A MX 2015013993 A MX2015013993 A MX 2015013993A MX 2015013993 A MX2015013993 A MX 2015013993A
- Authority
- MX
- Mexico
- Prior art keywords
- prostate cancer
- arrays
- methods
- biomarker detection
- individual
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/243—Colony Stimulating Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/245—IL-1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/246—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
La invención proporciona un método para determinar el estado de enfermedad asociada al cáncer de próstata en un individuo que comprende o que consiste en las etapas de: (a) proporcionar una muestra a ensayar desde el individuo ; y (b) determinar una marca del biomarcador de la muestra de ensayo mediante la medición de la expresión en la muestra de prueba de uno o más biomarcadores seleccionados del grupo que se define en la Tabla 1; en el que la expresión en la muestra de ensayo de los uno o más biomarcadores seleccionados del grupo que se define en la Tabla 1 es indicativo de uno o más estados de enfermedad asociados a cáncer de prostata en el individuo. La invención también proporciona matrices y kits para su uso en el mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1305940.7A GB201305940D0 (en) | 2013-04-02 | 2013-04-02 | Methods and arrays for use in the same |
PCT/EP2014/056630 WO2014161910A2 (en) | 2013-04-02 | 2014-04-02 | Methods and arrays for use in the same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015013993A true MX2015013993A (es) | 2016-07-07 |
Family
ID=48445139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015013993A MX2015013993A (es) | 2013-04-02 | 2014-04-02 | Procedimientos y series para su uso en los mismos. |
Country Status (12)
Country | Link |
---|---|
US (1) | US10048265B2 (es) |
EP (2) | EP3557259A3 (es) |
JP (1) | JP6674889B2 (es) |
KR (1) | KR102208140B1 (es) |
CN (1) | CN105283763B (es) |
AU (1) | AU2014247083B2 (es) |
BR (1) | BR112015025255A2 (es) |
CA (1) | CA2908527A1 (es) |
GB (1) | GB201305940D0 (es) |
HK (1) | HK1221504A1 (es) |
MX (1) | MX2015013993A (es) |
WO (1) | WO2014161910A2 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11450121B2 (en) * | 2017-06-27 | 2022-09-20 | The Regents Of The University Of California | Label-free digital brightfield analysis of nucleic acid amplification |
JP7412344B2 (ja) * | 2018-10-04 | 2024-01-12 | 大塚製薬株式会社 | 補助情報の取得方法 |
KR102543618B1 (ko) | 2021-05-27 | 2023-06-13 | 사회복지법인 삼성생명공익재단 | 전립선암의 엔잘루타미드 저항성 예측용 신규 바이오마커 및 이의 용도 |
EP4343335A1 (en) * | 2022-09-23 | 2024-03-27 | Diesse Diagnostica Senese S.p.a. | Apparatus for performing immunometric tests |
WO2024062057A1 (en) * | 2022-09-23 | 2024-03-28 | Diesse Diagnostica Senese S.P.A. | Apparatus for performing immunometric tests |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0039578B1 (en) | 1980-05-02 | 1985-04-10 | Edward P. Davis | Leg aid device |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
US5856090A (en) | 1994-09-09 | 1999-01-05 | The Scripps Research Institute | DNA-methylase linking reaction |
GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
US20060269971A1 (en) * | 2003-09-26 | 2006-11-30 | Mount Sinai Hospital | Methods for detecting prostate cancer |
US20100255518A1 (en) * | 2006-04-04 | 2010-10-07 | Goix Philippe J | Highly sensitive system and methods for analysis of troponin |
US20090017463A1 (en) | 2007-07-10 | 2009-01-15 | Vanderbilt University | Methods for predicting prostate cancer recurrence |
AU2008298560A1 (en) * | 2007-09-14 | 2009-03-19 | Ventana Medical Systems, Inc. | Prostate cancer biomarkers |
US8748118B2 (en) * | 2009-08-03 | 2014-06-10 | Yeda Research And Development Co. Ltd. | Urinary biomarkers for cancer diagnosis |
-
2013
- 2013-04-02 GB GBGB1305940.7A patent/GB201305940D0/en not_active Ceased
-
2014
- 2014-04-02 JP JP2016505813A patent/JP6674889B2/ja not_active Expired - Fee Related
- 2014-04-02 BR BR112015025255A patent/BR112015025255A2/pt not_active IP Right Cessation
- 2014-04-02 EP EP19157572.9A patent/EP3557259A3/en not_active Withdrawn
- 2014-04-02 CN CN201480030354.9A patent/CN105283763B/zh not_active Expired - Fee Related
- 2014-04-02 EP EP14717703.4A patent/EP2981827A2/en not_active Ceased
- 2014-04-02 US US14/781,839 patent/US10048265B2/en active Active
- 2014-04-02 CA CA2908527A patent/CA2908527A1/en not_active Abandoned
- 2014-04-02 WO PCT/EP2014/056630 patent/WO2014161910A2/en active Application Filing
- 2014-04-02 AU AU2014247083A patent/AU2014247083B2/en not_active Ceased
- 2014-04-02 KR KR1020157031458A patent/KR102208140B1/ko active IP Right Grant
- 2014-04-02 MX MX2015013993A patent/MX2015013993A/es active IP Right Grant
-
2016
- 2016-08-10 HK HK16109510.4A patent/HK1221504A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU2014247083B2 (en) | 2020-03-26 |
US20160041173A1 (en) | 2016-02-11 |
KR20150137118A (ko) | 2015-12-08 |
HK1221504A1 (zh) | 2017-06-02 |
JP6674889B2 (ja) | 2020-04-01 |
KR102208140B1 (ko) | 2021-01-27 |
WO2014161910A2 (en) | 2014-10-09 |
CN105283763A (zh) | 2016-01-27 |
EP2981827A2 (en) | 2016-02-10 |
WO2014161910A3 (en) | 2014-12-31 |
BR112015025255A2 (pt) | 2017-10-10 |
CA2908527A1 (en) | 2014-10-09 |
EP3557259A3 (en) | 2020-01-22 |
EP3557259A2 (en) | 2019-10-23 |
JP2016519767A (ja) | 2016-07-07 |
GB201305940D0 (en) | 2013-05-15 |
US10048265B2 (en) | 2018-08-14 |
AU2014247083A1 (en) | 2015-11-19 |
CN105283763B (zh) | 2018-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016006125A (es) | Procedimiento, matriz y uso de los mismos. | |
MX363201B (es) | Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico. | |
MX2018013621A (es) | Metodo, matriz y uso de estos. | |
WO2017050939A3 (en) | Method and array for diagnosing pancreatic cancer in an individual | |
MX2019008911A (es) | Metodos, matrices y usos de estos. | |
MX357119B (es) | Microarn plasmáticos para la detección de cáncer colorrectal temprano. | |
AR089825A1 (es) | Metodo para determinar la ubicacion, tamaño y condiciones in situ en un yacimiento de hidrocarburos con ecologia, geoquimica y grupos de biomarcadores | |
MX2020004617A (es) | Prediccion de riesgo de evento cardiovascular y usos del mismo. | |
MX2015006680A (es) | Composiciones y metodos para diagnosticar tumores de tiroides. | |
WO2014186761A3 (en) | Methods for determining responsiveness to an anti-cd47 agent | |
WO2015094995A3 (en) | Gene signature biomarkers of tumor response to pd-1 antagonists | |
GB201207297D0 (en) | Analytical methods and arrays for use in the same | |
MX2021006791A (es) | Metodos y composiciones para detectar proteinas mal plegadas. | |
EA030186B9 (ru) | Способ проведения количественных анализов | |
EP3575781A3 (en) | Test strips and method for reading test strips | |
WO2015189591A3 (en) | Method and arrays for use in diagnosing early breast cancer | |
GB201014837D0 (en) | Biomarker signatures and uses thereof | |
WO2015094996A3 (en) | Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists | |
MX2015013993A (es) | Procedimientos y series para su uso en los mismos. | |
WO2013188686A3 (en) | Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome | |
GB201206323D0 (en) | Methods and arrays for use in the same | |
WO2014162008A3 (en) | Biomarker signatures for predicting drug response in hodkin's lymphoma | |
WO2015091575A3 (en) | Different levels in blood cell samples of emt-markers for the diagnosis of cancer, in particular of colorectal (crc) and pancreatic (pc) cancer | |
MX2016001719A (es) | Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular. | |
MX371379B (es) | Deteccion de la actividad de corte de una enzima. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |